Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: a randomized clinical trial
June 4, 2020
Linzagolix
Jacques Donnez, M.D., Ph.D., Hugh S. Taylor, M.D., Ph.D., Robert N. Taylor, M.D., Ph.D., Mark D. Akin, M.D., Tatyana F. Tatarchuk, M.D., Dr. Sc., Krzysztof Wilk, M.D., Jean-Pierre Gotteland, Ph.D., Veronique Lecomte, Pharm.D., Elke Bestel, M.D.
Published online: June 03, 2020
Read moreGonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis
June 3, 2020
Linzagolix
Olivier Donnez M.D., Ph.D. , Jacques Donnez M.D., Ph.D.
Published online: June 02, 2020
Read moreLinzagolix for Endometriosis-Associated Pain: Lipid Changes After 52 Weeks of Treatment
April 24, 2020
Linzagolix
Bestel, Elke MD; Gotteland, Jean-Pierre PhD; Donnez, Jacques MD, PhD; Taylor, Robert N. MD, PhD; Garner, Elizabeth I. MD, MPH
ACOG Annual Conference, April 2020
Read moreQuality of Life Results After 52 Weeks of Treatment With Linzagolix for Endometriosis-Associated Pain
Linzagolix
Bestel, Elke MD; Gotteland, Jean-Pierre PhD; Donnez, Jacques MD, PhD; Taylor, Robert N. MD, PhD; Garner, Elizabeth I. MD, MPH
ACOG Annual Conference, April 2020
Read moreEffects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding-delayed add-back onset does not improve bleeding pattern
February 26, 2020
Linzagolix
Pohl O., Marchand L., Bell D., Gotteland JP.
Read moreBabies Born Following Administration of Nolasiban Before Embryo Transfer (ET) After IVF: Neonatal and Infant Development Outcomes From a Double-Blind, Placebo-Controlled, Clinical Trial
October 7, 2019
Nolasiban
Humberstone A., Terrill P., Macgregor L., Loumaye E.
ASRM 2019 Scientific Congress & Expo, 12-16 October 2019, Philadelphia, PA
Fertility and Sterility Vol. 112, No. 3, Supplement, September 2019. Abstract on pages e7-e8.
Read moreLong Term Treatment of Endometriosis Associated Pain (EAP) With Linzagolix: Efficacy and Safety After 12 Months of Treatment
Linzagolix
Taylor R., Bestel E., Gotteland JP., Lecomte V., Dubouloz R., Terrill P., Humberstone A., Loumaye E.
ASRM 2019 Scientific Congress & Expo, 12-16 October 2019, Philadelphia, PA
Fertility and Sterility Vol. 112, No. 3, Supplement, September 2019. Abstract on page e323.
Read moreThe Effect of Linzagolix on Bone Mineral Density (BMD): Safety Results From a Dose-Ranging Trial
May 20, 2019
Linzagolix
Elke Bestel, Andrew Humberstone, Veronique Lecomte, Ernest Loumaye, Jean-Pierre Gotteland, James A. Simon
ACOG Annual Conference, 03-06 May 2019, Nashville, TN
Read moreOxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F2α-induced Contractions and Inflammatory Responses in Human Myometrium
April 8, 2019
Nolasiban
Sung Hye Kim, Lucia Riaposova, Hauwa Ahmed, Oliver Pohl, André Chollet, Jean-Pierre Gotteland, Aylin Hanyaloglu, Phillip R. Bennett & Vasso Terzidou
Read moreCo‐administration of the prostaglandin F2α receptor antagonist pre‐term labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone
March 25, 2019
OBE022
Oliver Pohl, Line Marchand, Jean‐Pierre Gotteland, Simon Coates, Jörg Täubel, Ulrike Lorch
Read more